Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Dine Brands
DIN
$458M
| $13.4M | ﹤0.01% |
176,163
+3,348
| +2% | +$271K |
|
1852
Riot Platforms
RIOT
$8.1B
| $13.3M | ﹤0.01% |
596,626
+19,740
| +3% | +$588K |
|
1853
Strategic Education
STRA
$1.89B
| $13.3M | ﹤0.01% |
229,646
+17,552
| +8% | +$1.1M |
|
1854
Domo
DOMO
$184M
| $13.2M | ﹤0.01% |
266,647
+823
| +0.3% | +$60.5K |
|
1855
Surgery Partners
SGRY
$2.1B
| $13.2M | ﹤0.01% |
247,310
+35,036
| +17% | +$1.62M |
|
|
BBT
1856
Beacon Financial Corp
BBT
$2.69B
| $13.2M | ﹤0.01% |
463,712
+3,640
| +0.8% | +$101K |
|
|
BWIN
1857
Baldwin Insurance Group
BWIN
$2.85B
| $13.2M | ﹤0.01% |
364,379
+16,781
| +5% | +$620K |
|
|
AAMI
1858
Acadian Asset Management
AAMI
$3.2B
| $13.1M | ﹤0.01% |
513,617
-93,582
| -15% | -$2.63M |
|
1859
NMI Holdings
NMIH
$3.35B
| $13.1M | ﹤0.01% |
601,036
+8,597
| +1% | +$191K |
|
1860
Iovance Biotherapeutics
IOVA
$1.93B
| $13.1M | ﹤0.01% |
685,459
+19,563
| +3% | +$431K |
|
|
CCXI
1861
DELISTED
ChemoCentryx, Inc.
CCXI
| $13.1M | ﹤0.01% |
359,046
+32,613
| +10% | +$1.14M |
|
1862
Arcus Biosciences
RCUS
$3.47B
| $13M | ﹤0.01% |
322,150
-33,091
| -9% | -$1.28M |
|
1863
Enovix
ENVX
$921M
| $13M | ﹤0.01% |
545,542
+9,364
| +2% | +$227K |
|
1864
Alight
ALIT
$517M
| $13M | ﹤0.01% |
60,225
+1,037
| +2% | +$225K |
|
|
CHCT
1865
Community Healthcare Trust
CHCT
$522M
| $13M | ﹤0.01% |
275,061
+10,984
| +4% | +$504K |
|
1866
ADT
ADT
$5.76B
| $12.9M | ﹤0.01% |
1,539,076
+162,795
| +12% | +$1.39M |
|
|
WE
1867
DELISTED
WeWork Inc.
WE
| $12.9M | ﹤0.01% |
+37,623
| New | +$13.8M |
|
1868
Cimpress
CMPR
$2.4B
| $12.9M | ﹤0.01% |
180,725
+13,278
| +8% | +$1.09M |
|
1869
Editas Medicine
EDIT
$407M
| $12.9M | ﹤0.01% |
484,786
+9,699
| +2% | +$334K |
|
1870
Virgin Galactic
SPCE
$362M
| $12.8M | ﹤0.01% |
47,917
+850
| +2% | +$307K |
|
1871
Invesco Mortgage Capital
IVR
$757M
| $12.8M | ﹤0.01% |
458,975
+72,406
| +19% | +$2.24M |
|
1872
Marcus & Millichap
MMI
$1.16B
| $12.7M | ﹤0.01% |
247,710
+6,698
| +3% | +$312K |
|
1873
First Busey Corp
BUSE
$2.6B
| $12.7M | ﹤0.01% |
469,376
+36,672
| +8% | +$971K |
|
1874
Addus HomeCare
ADUS
$2.18B
| $12.7M | ﹤0.01% |
136,014
+9,763
| +8% | +$878K |
|
1875
Rocket Lab Corp
RKLB
$44B
| $12.7M | ﹤0.01% |
+1,034,703
| New | +$14.2M |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.